Logo image
Back
3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab
Journal article   Peer reviewed

3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab

Yang Li, Ting Zhang, Yuan Pang, Ling Li, Zhi-Nan Chen and Wei Sun
Biofabrication, v 11(3), pp 034102/1-034102/13
26 Jun 2019
DOI: https://doi.org/10.1088/1758-5090/ab256c
PMID: 31141796
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

3D printing hepatoma model Metuzumab microfluidics
Constructing in vitro drug models with a higher degree of bionics is considered to be an important approach to improve the effectiveness of existing drug screening models. 3D printing, co-culture and microfluidics are important methods that commonly used. This study combined the advantages of the three methods. A 3D co-culture microfluidic model with controllable hepatoma cluster size was constructed, and applied to pharmacodynamic tests of a new anti-CD147 monoclonal antibody, Metuzumab. In the phase of cell preparation, hepatoma cells in the new model were found to proliferate faster than common in vitro 3D models fabricated by cell printing only. The hepatoma cells were also found less affected by the increase of drug dosage in migration performance, proliferation performance and protein expression level in the new model compared with 2D models. These results are in line with those obtained from animal experiments and clinical trials of similar anti-CD147 antibody drugs. In view of the special mechanism of antibody drugs, a modified model was built by adding peripheral blood mononuclear cells into the new model as effector cells, porting traditional antibody-dependent cell-mediated cytotoxicity (ADCC) test to a co-culture 3D microfluidic microenvironment. The results showed that ADCC exhibited higher effectiveness in the microfluidic model than in 3D printing models under the same dose of drug treatment. The new model was proved constructive and it provided a valuable reference for complex in vitro hepatoma model studies and antibody drug screening researches.

Metrics

10 Record Views
54 citations in Web of Science
58 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#9 Industry, Innovation and Infrastructure

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Engineering, Biomedical
Materials Science, Biomaterials
Logo image